Home / Science / Living Skin Gel Promises Scar-Free Healing
Living Skin Gel Promises Scar-Free Healing
6 Jun
Summary
- New 'skin in a syringe' gel can be injected or 3D printed.
- Fibroblasts are grown on porous gelatin microcarriers.
- Implants showed new blood vessel formation in mice.

A significant advancement in wound care has emerged from Sweden, where scientists have developed a novel 'skin in a syringe' technology. This innovative living gel, loaded with fibroblasts, offers the potential for scar-free skin regeneration. It can be injected directly into wounds or precisely 3D printed, facilitating the body's ability to rebuild functional skin.
The research, conducted at Linköping University, focuses on using fibroblasts, the key cells in the dermis, grown on porous gelatin microcarriers. This approach aims to provide the building blocks for the dermis, which is notoriously difficult to regenerate with current treatments like split-thickness skin grafts.
The resultant gel, a combination of these cell-loaded particles and hyaluronic acid, exhibits shear-thinning properties. This allows it to be easily applied via syringe or 3D printing, yet it solidifies upon application, remaining stable in the wound site. Crucially, the porous gel structure supports cell viability and nutrient exchange while gradually degrading as healing progresses.
Laboratory tests demonstrated that the fibroblasts within the gel produced essential proteins like collagen, aiding in the formation of a structure resembling normal dermis rather than scar tissue. Subsequent implantation in mice showed that the cells survived, proliferated, and importantly, stimulated the formation of new blood vessels.
This development holds promise not only for burn and chronic wound patients but also for broader applications in regenerative medicine. The ability to facilitate blood vessel growth is a major hurdle in engineering larger tissues and organs. The technology is still experimental, with further testing in larger animal models planned before it can reach clinical application.